Review Article STROKES IN COVID- 19: STROKES IN COVID- 19

RAJESH BENNY

doi:10.15713/ins.bhj.78

Authors

RAJESH BENNY Professor of Neurology, Senior Consultant Neurologist, Fortis Hospital, Mulund, Mumbai, India

DOI:

https://doi.org/10.15713/ins.bhj.78

Abstract

The coronavirus disease 2019 (COVID-19) pandemic that is ravaging the world is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS- CoV- 2). The dominant features of COVID- 19 are fever, respiratory and gastro intestinal; however, it is also known to cause neurological complications. Even early in the pandemic thrombotic complications associated with COVID- 19 were recognised including COVID- 19 associated acute ischemic strokes (AIS).

References

R Benny, RK Singh, A Venkitachalam, et al., Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19. J Neurol Sci. 2021 Apr 15;423:117348. doi: 10.1016/j.jns.2021.117348. Epub 2021 Feb 17. PMID: 33636660; PMCID: PMC7887446.

Tu TM, CYH Seet, JS Koh, et al. Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men. JAMA Netw Open. 2021 Apr 1;4(4):e217498. doi: 10.1001/jamanetworkopen.2021.7498. PMID: 33885771; PMCID: PMC8063067.

I. Siow, K.S. Lee, J.J.Y. Zhang, et al., Stroke as a neurological complication of COVID-19: a systematic review and meta-analysis of incidence, outcomes and predictors, J. Stroke Cerebrovasc. Dis. 30 (3) (2020 Dec 15) 105549, https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105549. Epub ahead of print. PMID: 33341565.

G. Ntaios, et al., Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19-19 stroke registry, Stroke 51 (9) (2020 Sep) e254–e258, https://doi.org/10.1161/STROKEAHA.120.031208. Epub 2020 Jul 9. PMID: 32787707; PMCID: PMC7359900.

L. Mao, H. Jin, M. Wang, et al., Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China, JAMA Neurol. 77 (2020) 683–690, https://doi.org/10.1001/jamaneurol.2020.1127.

Y. Li, M. Li, M. Wang, et al., Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study, Stroke Vasc. Neurol. 5 (3) (2020 Sep) 279–284, https://doi.org/10.1136/svn- 2020-000431. Epub 2020 Jul 2. PMID: 32616524; PMCID: PMC7371480.

R Beyrouti, ME Adams, L Benjamin, et al., Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. doi: 10.1136/jnnp-2020-323586. Epub 2020 Apr 30. PMID: 32354768; PMCID: PMC7231545.

S Nannoni, R de Groot, S Bell, et al. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021 Feb;16(2):137-149. doi: 10.1177/1747493020972922. Epub 2020 Nov 11. PMID: 33103610; PMCID: PMC7859578.

S Rudilosso , C Laredo, V Vera, et al., Acute stroke care is at risk in the era of COVID-19:Experience at a comprehensive stroke center in Barcelona. Stroke 2020;51:1991–5.

JE Siegler, ME Heslin, L Thau., et al. Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center. J Stroke Cerebrovasc Dis 2020;29:104953.

M Sharma, V-A Lioutas, T Madsen, et al., Decline in stroke alerts and hospitalisations during the COVID-19 pandemic. Stroke Vasc Neurol 2020. doi:10.1136/svn-2020-000441. Epub ahead of print: 27 Aug 2020.

D Aguiar de Sousa, EC Sandset, MSV Elkind. The curious case of the missing strokes during the COVID-19 pandemic. Stroke 2020;51:1921–3.

AE Merkler, NS Parikh, S Mir, et al., Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020 Jul 2;77(11):1–7. doi: 10.1001/jamaneurol.2020.2730. Epub ahead of print. PMID: 32614385; PMCID: PMC7333175.

G. Trifan, F.D. Goldenberg, F.Z. Caprio, et al., Characteristics of a diverse cohort of stroke patients with SARS-CoV-2 and outcome by sex, J. Stroke Cerebrovasc. Dis. 29 (11) (2020 Nov) 105314, https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105314. Epub 2020 Sep 11. PMID:32951959; PMCID: PMC7486061.

T.J. Oxley, J. Mocco, S. Majidi, et al., Large-vessel stroke as a presenting feature of COVID-19 in the young, N. Engl. J. Med. 382 (20) (2020), e60, https://doi.org/10.1056/NEJMc2009787.

S. Yaghi, K. Ishida, J. Torres, et al., SARS-CoV-2 and stroke in a New York Healthcare System, Stroke 51 (7) (2020 Jul) 2002–2011, https://doi.org/10.1161/STROKEAHA.120.030335. Epub 2020 May 20. Erratum in: Stroke. 2020 Aug;51(8):e179. PMID: 32432996; PMCID:PMC7258764.

S Ahmadi Karvigh, F Vahabizad, G Banihashemi, et al., Ischemic Stroke in Patients with COVID-19 Disease: A Report of 10 Cases from Iran. Cerebrovasc Dis. 2021;50(2):239-244. doi: 10.1159/000513279. Epub 2020 Dec 15. PMID: 33321492; PMCID: PMC7801957.

K South, L McCulloch, BW McColl, et al., Preceding infection and risk of stroke: an old concept revived by the COVID-19 pandemic. Int J Stroke 2020; 15: 722–732.

B Engelmann , S Massberg. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34–45.

SG Lee, M Fralick, M Sholzberg. Coagulopathy associated with COVID-19. CMAJ.2020;192(21):E583.

C Magro, JJ Mulvey, D Berlin, et al., Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res.2020;220:1-13.

RC Becker. COVID-19 update: COVID-19 associated coagulopathy. J Thromb Thrombolysis.2020;50:54-67.

A Zakeri, AP Jadhav, BA Sullenger, et al., Ischemic stroke in COVID-19 positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointervent Surg.2021;13:202-206.

D McGonagle, JS O'Donnell, K Sharif, et al., Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol 2020;2:e437–45.doi:10.1016/S2665-9913(20)30121-1. pmid:http://www.ncbi.nlm.nih.gov/pubmed/32835247.

JD Spence, GR de Freitas, LC Pettigrew, et al., Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-458. doi: 10.1159/000509581. Epub 2020 Jul 20. PMID: 32690850; PMCID: PMC7445374.

J. Cermak, N.S. Key, R.R. Bach, et al., C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor, Blood 82 (1993) 513–520.

J. Zhang, Y. Song, B. Shan, et al., Elevated level of D-dimer increases the risk of stroke, Oncotarget 9 (2) (2017 Dec 18) 2208–2219, https://doi.org/10.18632/oncotarget.23367. PMID: 29416765; PMCID: PMC5788633.

WJ Guan, ZY Ni, Y Hu, et al., China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28. PMID: 32109013; PMCID: PMC7092819.

Y Zhang, M Xiao, S Zhang, et al., Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8. PMID: 32268022; PMCID: PMC7161262.

M Gatto, C Perricone, M Tonello, et al. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):754-759. Epub 2020 Jul 28. PMID: 32723434.

Z Varga, AJ Flammer, P Steiger, et al., Endothelial cell infection and endotheliitis in COVID-19. Lancet.2020;395(10234):1417-8.

PO Bonetti, LO Lerman, A Lerman. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. doi: 10.1161/01.atv.0000051384.43104.fc. PMID: 12588755.

MG Fara, LK Stein, M Skliut, et al., Macrothrombosis and stroke in patients with mild Covid-19 infection. J Thromb Haemost 2020;18:2031-3. doi:10.1111/jth.14938 pmid:http://www.ncbi.nlm.nih.gov/pubmed/32464707.

R Cheng, D Leedy. COVID and acute myocardial injury: The heart of the matter or an innocent bystander? Heart.2020.

M Madjid, P Safavi-Naeini, SD Solomon, et al., Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol.2020.

DC Hess, W Eldahshan, Rutkowski E. COVID-19 related stroke, Transl Stroke Res.2020;11:322-25.

SJ Cameron, DS Mix, SK Ture, et al: Hypoxia and ischemia promote a maladaptive platelet phenotype. Arterioscler Thromb Vasc Biol. 38:1594–1606. 2018.

N Gupta, YY Zhao and CE Evans: The stimulation of thrombosis by hypoxia. Thromb Res. 181:77–83. 2019.

NR Smilowitz, V Subashchandran, E Yuriditsky, et al., Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am Heart J. 2021 Jan;231:93-95. doi: 10.1016/j.ahj.2020.10.075. Epub 2020 Nov 10. PMID: 33181067; PMCID: PMC7654304.

N Tang, H Bai, X Chen, et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020;18:1094–9.

T Iba, JH Levy, JM Connors, et al. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020 Jun 18;24(1):360. doi: 10.1186/s13054-020-03077-0. PMID: 32552865; PMCID: PMC7301352.

EM Gavioli, G Sikorska, A Man, et al., Current perspectives of anticoagulation in patients with COVID-19. J Cardiovasc Pharmacol 2020;76:146–50.

PJ Hsu, CH Chen, SJ Yeh, et al., High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis. Cerebrovasc Dis. 2016;42(1-2):117-21. doi: 10.1159/000445037. Epub 2016 Apr 19. PMID: 27088493.

RJ Perry, CJ Smith, C Roffe on behalf of the SETICOS collaborators, et al., Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. Journal of Neurology, Neurosurgery &Psychiatry 2021;92:242-248.

G Aggarwal, G Lippi, B Michael Henry. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. Int J Stroke. 2020 Jun;15(4):385-389. doi: 10.1177/1747493020921664. Epub 2020 Apr 20. PMID: 32310015.

P Fujun, Tu Lei, Y Yongshi, et al., Management and treatment of COVID-19: the Chinese experience, Can. J. Cardiol. 36 (2020) 915–930.